VERTEX PHARMACEUTICALS INC / MA Quarterly Inventory, Net in USD from Q1 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
Summary
Vertex Pharmaceuticals Inc / Ma quarterly Inventory, Net history and growth rate from Q1 2011 to Q3 2024.
  • Vertex Pharmaceuticals Inc / Ma Inventory, Net for the quarter ending September 30, 2024 was $1.08B, a 56.8% increase year-over-year.
Inventory, Net, Quarterly (USD)
Inventory, Net, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.08B +$391M +56.8% Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $915M +$311M +51.5% Jun 30, 2024 10-Q 2024-08-02
Q1 2024 $813M +$278M +52% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $739M +$278M +60.4% Dec 31, 2023 10-Q 2024-11-05
Q3 2023 $689M +$301M +77.4% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $604M +$236M +64.1% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $535M +$196M +57.9% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 $461M +$108M +30.4% Dec 31, 2022 10-K 2024-02-15
Q3 2022 $388M +$54.7M +16.4% Sep 30, 2022 10-Q 2022-10-28
Q2 2022 $368M +$46.1M +14.3% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $339M +$40M +13.4% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $353M +$72.3M +25.7% Dec 31, 2021 10-K 2023-02-10
Q3 2021 $333M +$88M +35.8% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $322M +$102M +46.7% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 $299M +$112M +59.7% Mar 31, 2021 10-Q 2021-04-30
Q4 2020 $281M +$113M +67.6% Dec 31, 2020 10-K 2022-02-09
Q3 2020 $245M +$83.2M +51.2% Sep 30, 2020 10-Q 2020-10-30
Q2 2020 $219M +$76.2M +53.3% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $187M +$50.4M +36.9% Mar 31, 2020 10-Q 2020-05-01
Q4 2019 $168M +$43.1M +34.7% Dec 31, 2019 10-K 2021-02-11
Q3 2019 $162M +$38.2M +30.7% Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $143M +$28M +24.3% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $137M +$19.4M +16.5% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $124M +$12.5M +11.2% Dec 31, 2018 10-K 2020-02-13
Q3 2018 $124M +$26M +26.4% Sep 30, 2018 10-Q 2018-10-25
Q2 2018 $115M +$22.8M +24.7% Jun 30, 2018 10-Q 2018-07-26
Q1 2018 $117M +$35.3M +43.1% Mar 31, 2018 10-Q 2018-04-27
Q4 2017 $112M +$34.2M +44.1% Dec 31, 2017 10-K 2019-02-13
Q3 2017 $98.2M +$26.4M +36.8% Sep 30, 2017 10-Q 2017-10-30
Q2 2017 $92.3M +$25.7M +38.6% Jun 30, 2017 10-Q 2017-07-28
Q1 2017 $82M +$18.8M +29.8% Mar 31, 2017 10-Q 2017-04-28
Q4 2016 $77.6M +$20.4M +35.7% Dec 31, 2016 10-K 2018-02-15
Q3 2016 $71.8M +$22.6M +45.9% Sep 30, 2016 10-Q 2016-10-31
Q2 2016 $66.6M +$24.5M +58.1% Jun 30, 2016 10-Q 2016-08-01
Q1 2016 $63.2M +$29.1M +85.4% Mar 31, 2016 10-Q 2016-05-03
Q4 2015 $57.2M +$26.4M +85.4% Dec 31, 2015 10-K 2017-02-23
Q3 2015 $49.2M +$32.4M +194% Sep 30, 2015 10-Q 2015-10-30
Q2 2015 $42.1M +$30.1M +251% Jun 30, 2015 10-Q 2015-08-04
Q1 2015 $34.1M +$22.8M +203% Mar 31, 2015 10-Q 2015-05-04
Q4 2014 $30.8M +$16.7M +118% Dec 31, 2014 10-K 2016-02-16
Q3 2014 $16.8M +$3.22M +23.8% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 $12M -$7.53M -38.6% Jun 30, 2014 10-Q 2014-07-31
Q1 2014 $11.3M -$10.3M -47.7% Mar 31, 2014 10-Q 2014-05-05
Q4 2013 $14.1M -$16.3M -53.6% Dec 31, 2013 10-K 2015-02-13
Q3 2013 $13.5M -$72.7M -84.3% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 $19.5M -$68.3M -77.8% Jun 30, 2013 10-Q 2013-08-02
Q1 2013 $21.5M -$108M -83.4% Mar 31, 2013 10-Q 2013-05-08
Q4 2012 $30.5M -$82M -72.9% Dec 31, 2012 10-K 2014-02-11
Q3 2012 $86.3M +$18.6M +27.5% Sep 30, 2012 10-Q 2012-11-06
Q2 2012 $87.8M +$35.2M +66.9% Jun 30, 2012 10-Q 2012-08-08
Q1 2012 $130M +$112M +627% Mar 31, 2012 10-Q 2012-05-10
Q4 2011 $112M Dec 31, 2011 10-K 2013-03-01
Q3 2011 $67.7M Sep 30, 2011 10-Q 2011-11-03
Q2 2011 $52.6M Jun 30, 2011 10-Q 2011-08-09
Q1 2011 $17.8M Mar 31, 2011 10-Q 2011-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.